Work

Figure S3 from Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression

Year: 2023

Type: other

Abstract: MAML3 increases cell viability. SK-N-SH, QGP-1 and BON-1 transfected with FL or dEx1 MAML3 showed increased cell viability by Cell Titer Glo assay (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001)

DOI: 10.1158/1541-7786.22526528.v1

Authors: Nathaniel Alzofon, Katrina Koc, Kristin Panwell, Nikita Pozdeyev, Carrie B. Marshall, Maria Albuja-Cruz, Christopher D. Raeburn, Katherine L. Nathanson, Debbie L. Cohen, Margaret E. Wierman, Katja Kiseljak-Vassiliades, Lauren Fishbein

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362626005

Cites:

Cited by:

Related to: 10